Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 May 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Oct 4;18(5):1197–1206.e7. doi: 10.1016/j.cgh.2019.09.033

Figure 3. — Cumulative probability curves comparing the resolution of HE in patients with SVR versus those without SVR among all patients or clinically-relevant subgroups.

a. All patients

b. By antiviral regimen

c. By MELD category

DAA = direct acting antivirals, IFN = interferon, MELD = model for endstage liver disease, SVR = sustained virologic response

Figure 3. — Cumulative probability curves comparing the resolution of HE in patients with SVR versus those without SVR among all patients or clinically-relevant subgroups.

a. All patients

b. By antiviral regimen

c. By MELD category

DAA = direct acting antivirals, IFN = interferon, MELD = model for endstage liver disease, SVR = sustained virologic response